يعرض 1 - 10 نتائج من 27 نتيجة بحث عن '"Pyrrole Derivative"', وقت الاستعلام: 1.02s تنقيح النتائج
  1. 1
    مورد إلكتروني

    مصطلحات الفهرس: female, hormone action, hormone response, mouse, nonhuman, ovariectomy, priority journal, review, time, 2 butanone, 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid/cm [Drug Comparison], 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid/do [Drug Dose], 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid/pd [Pharmacology], 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid/sc [Subcutaneous Drug Administration], anesthetic agent, angiogenesis inhibitor/cm [Drug Comparison], angiogenesis inhibitor/do [Drug Dose], angiogenesis inhibitor/pd [Pharmacology], angiogenesis inhibitor/sc [Subcutaneous Drug Administration], arachis oil, bromethol, estrogen/cb [Drug Combination], estrogen/do [Drug Dose], estrogen/pd [Pharmacology], fibroblast growth factor/ec [Endogenous Compound], platelet derived growth factor/ec [Endogenous Compound], progesterone/cm [Drug Comparison], progesterone/pd [Pharmacology], pyrrole derivative/cm [Drug Comparison], pyrrole derivative/do [Drug Dose], pyrrole derivative/pd [Pharmacology], pyrrole derivative/sc [Subcutaneous Drug Administration], receptor blocking agent/cm [Drug Comparison], receptor blocking agent/do [Drug Dose], receptor blocking agent/pd [Pharmacology], receptor blocking agent/sc [Subcutaneous Drug Administration], semaxanib/cm [Drug Comparison], semaxanib/do [Drug Dose], semaxanib/pd [Pharmacology], semaxanib/sc [Subcutaneous Drug Administration], sex hormone/cb [Drug Combination], sex hormone/do [Drug Dose], sex hormone/pd [Pharmacology], sodium chloride, tyrosine kinase receptor/ec [Endogenous Compound], unclassified drug, vasculotropin/ec [Endogenous Compound], vasculotropin antibody/cb [Drug Combination], vasculotropin antibody/cm [Drug Comparison], vasculotropin antibody/do [Drug Dose], vasculotropin antibody/ip [Intraperitoneal Drug Administration], vasculotropin antibody/pd [Pharmacology], su 11652/cm [Drug Comparison], su 11652/do [Drug Dose], su 11652/pd [Pharmacology], su 11652/sc [Subcutaneous Drug Administration], su 11685/cm [Drug Comparison], su 11685/do [Drug Dose], su 11685/pd [Pharmacology], su 11685/sc [Subcutaneous Drug Administration], low drug dose, age, angiogenesis, animal cell, animal experiment, animal tissue, cell activity, cell cycle, cell proliferation, controlled study, dose response, drug effect, drug mechanism, endometrium cell, endothelium cell, estrogen therapy, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32708Test
    Click here for full text options
    LibKey Link

  2. 2
    مورد إلكتروني

    مصطلحات الفهرس: female, hormone action, hormone response, mouse, nonhuman, ovariectomy, priority journal, review, time, 2 butanone, 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid/cm [Drug Comparison], 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid/do [Drug Dose], 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid/pd [Pharmacology], 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid/sc [Subcutaneous Drug Administration], anesthetic agent, angiogenesis inhibitor/cm [Drug Comparison], angiogenesis inhibitor/do [Drug Dose], angiogenesis inhibitor/pd [Pharmacology], angiogenesis inhibitor/sc [Subcutaneous Drug Administration], arachis oil, bromethol, estrogen/cb [Drug Combination], estrogen/do [Drug Dose], estrogen/pd [Pharmacology], fibroblast growth factor/ec [Endogenous Compound], platelet derived growth factor/ec [Endogenous Compound], progesterone/cm [Drug Comparison], progesterone/pd [Pharmacology], pyrrole derivative/cm [Drug Comparison], pyrrole derivative/do [Drug Dose], pyrrole derivative/pd [Pharmacology], pyrrole derivative/sc [Subcutaneous Drug Administration], receptor blocking agent/cm [Drug Comparison], receptor blocking agent/do [Drug Dose], receptor blocking agent/pd [Pharmacology], receptor blocking agent/sc [Subcutaneous Drug Administration], semaxanib/cm [Drug Comparison], semaxanib/do [Drug Dose], semaxanib/pd [Pharmacology], semaxanib/sc [Subcutaneous Drug Administration], sex hormone/cb [Drug Combination], sex hormone/do [Drug Dose], sex hormone/pd [Pharmacology], sodium chloride, tyrosine kinase receptor/ec [Endogenous Compound], unclassified drug, vasculotropin/ec [Endogenous Compound], vasculotropin antibody/cb [Drug Combination], vasculotropin antibody/cm [Drug Comparison], vasculotropin antibody/do [Drug Dose], vasculotropin antibody/ip [Intraperitoneal Drug Administration], vasculotropin antibody/pd [Pharmacology], su 11652/cm [Drug Comparison], su 11652/do [Drug Dose], su 11652/pd [Pharmacology], su 11652/sc [Subcutaneous Drug Administration], su 11685/cm [Drug Comparison], su 11685/do [Drug Dose], su 11685/pd [Pharmacology], su 11685/sc [Subcutaneous Drug Administration], low drug dose, age, angiogenesis, animal cell, animal experiment, animal tissue, cell activity, cell cycle, cell proliferation, controlled study, dose response, drug effect, drug mechanism, endometrium cell, endothelium cell, estrogen therapy, Review

  3. 3
    مورد إلكتروني
  4. 4
    مورد إلكتروني
  5. 5
    مورد إلكتروني
  6. 6
    مورد إلكتروني
  7. 7
    مورد إلكتروني
  8. 8
    مورد إلكتروني
  9. 9
    مورد إلكتروني
  10. 10